Tomoya Terashima
Overview
Explore the profile of Tomoya Terashima including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
761
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zen R, Tsuji S, Tomoko M, Maeda T, Urushitani M, Murakami T, et al.
Mol Ther
. 2025 Mar;
PMID: 40057827
Neonatal hypoxic-ischemic encephalopathy is aggravated by intracerebral inflammation. As pro-inflammatory microglia in the brain become activated in this condition, we aimed to establish a novel peptide therapy for neonatal hypoxic-ischemic...
2.
Tanaka K, Kitamura A, Nakamura R, Yamakawa I, Terashima T, Urushitani M
Rinsho Shinkeigaku
. 2025 Feb;
PMID: 39993771
We present the case of a 33-year-old man with progressive weakness in the left wrist and finger extensors. Initially, posterior interosseous nerve (PIN) palsy was suspected. However, nerve conduction studies...
3.
Nakamura R, Kurihara M, Kobashi S, Tamaki Y, Ogawa N, Kitamura A, et al.
Front Neurol
. 2023 Nov;
14:1286153.
PMID: 38020597
Introduction: This study sought to identify the optimal caloric intake to improve function and survival in ALS patients by comparing oral intake per ideal body weight (IBW) and its discrepancy...
4.
Kitamura T, Terashima T, Katagi M, Ohashi N, Nozaki K, Tsuji A
Cytotherapy
. 2023 Aug;
25(11):1186-1199.
PMID: 37552144
Background Aims: Stroke is a frequently observed neurological disorder that might lead to permanent and severe disability. Recently, various regenerative therapies have been developed, some of which have already been...
5.
Fujikawa H, Kojima H, Terashima T, Katagi M, Yayama T, Kumagai K, et al.
BMC Musculoskelet Disord
. 2023 Jul;
24(1):585.
PMID: 37464323
Background: Diabetes mellitus (DM) causes bone dysfunction due to poor bone quality, leading to severe deterioration in patient of quality of life. The mechanisms of bone metabolism in DM remain...
6.
Terashima T, Katagi M, Ohashi N
Stem Cells Transl Med
. 2023 Mar;
12(4):215-220.
PMID: 36976582
Diabetic neuropathy is a major complication of diabetes mellitus that occurs during the early stages of the disease. Many pathogenic mechanisms are related and induced by hyperglycemia. However, even if...
7.
Zen R, Terashima T, Tsuji S, Katagi M, Ohashi N, Nobuta Y, et al.
Front Pediatr
. 2022 May;
10:883556.
PMID: 35601427
Background: The pathophysiology of neonatal hypoxic-ischemic encephalopathy (HIE) has been studied in several rodent models to develop novel treatments. Although it is well known that high ambient temperature results in...
8.
Kobashi S, Terashima T, Katagi M, Urushitani M, Kojima H
Cytotherapy
. 2022 Apr;
24(8):789-801.
PMID: 35393241
Background Aims: Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disease. Neuroinflammation in the spinal cord plays a pivotal role in the pathogenesis of ALS, and microglia are involved in...
9.
Ohashi N, Terashima T, Katagi M, Nakae Y, Okano J, Suzuki Y, et al.
Sci Rep
. 2021 Jun;
11(1):12803.
PMID: 34140581
Amyotrophic lateral sclerosis (ALS) is an intractable neurodegenerative disease. CD68-positive bone marrow (BM)-derived cells (BMDCs) accumulate in the pathological lesion in the SOD1(G93A) ALS mouse model after BM transplantation (BMT)....
10.
Katagi M, Terashima T, Ohashi N, Nakae Y, Yamada A, Nakagawa T, et al.
Commun Biol
. 2021 May;
4(1):575.
PMID: 33990693
Diabetic neuropathy is an incurable disease. We previously identified a mechanism by which aberrant bone marrow-derived cells (BMDCs) pathologically expressing proinsulin/TNF-α fuse with residential neurons to impair neuronal function. Here,...